Molecule intelOpportunity: Lower0Crowded market

Losartan Potassium

280 brands · 115 companies · product forms

Opportunity snapshot

Launch attractiveness
24
Market saturation
100
Price room
100
Regulatory risk
0
280
brands
115
companies
Rs 396.37
median price
323
price points
313.65x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 75.28
MedianRs 396.37
Most expensiveRs 23,611.2
Spread313.65×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 313.65x across 323 trusted points (Rs 75.28-23611.2). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Losartan Potassium — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

115 canonical companies and 280 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 313.65x across 323 trusted points (Rs 75.28-23611.2). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.